Compare

Compare stocks side by side

Pick up to 3 companies to see where each one is stronger or weaker.

ACADABUS

Acadia Pharmaceuticals Inc.

ACAD · $19.73

66Good

Arbutus Biopharma Corp

ABUS · $4.20

78Strong

Area by area

Overall Quant Score

How does it look overall? (out of 100)

ACAD

66/100

ABUS

78/100

Quality

Is it a profitable, well-run business?

ACAD

6.4/10

ABUS

10.0/10

Growth

Is the company growing?

ACAD

7.8/10

ABUS

8.0/10

Valuation

Is the price reasonable? (higher = cheaper)

ACAD

6.5/10

ABUS

7.5/10

Risk

How risky are the shares? (higher = lower risk)

ACAD

6.4/10

ABUS

7.3/10

Momentum

Is the share price trending up?

ACAD

5.5/10

ABUS

5.5/10

Financial strength

Is the balance sheet healthy?

ACAD

7.6/10

ABUS

9.0/10

The balanced view

Model-generated

Acadia Pharmaceuticals Inc.

This company scores above average, with solid growth and a healthy balance sheet.

Leads on: momentum

Best feature: solid growth (Net income growth (FY): 72.7%)

Watch out: weakest area: analyst view (90-day rating revisions: 0↑ / 1↓)

Arbutus Biopharma Corp

This company scores well across most areas, with strong profitability and supportive analyst views.

Leads on: quality, growth, valuation, risk, momentum, financial strength

Best feature: strong profitability (Return on equity (TTM): 91.0%)

Watch out: weakest area: price momentum (Signal consensus: Strong Sell)

Different strengths suit different goals — a higher score in one area doesn’t make a stock the better choice for everyone.